<a href=

Regional website



http://www.art-er.it

target="_blank" style="text-decoration: underline">

Regional website



http://www.art-er.it

Emilia Romagna (ITH5)

Emilia-Romagna is a region in the northeast of Italy comprising the historical regions of Emilia and Romagna, it has a population of 4.5 million. It is home to the University of Bologna, which was founded in 1088 and is the oldest university in the world.

 

The region has a focus on the emerging fields of regenerative and restorative medicine, as well as pharmaceutical and omics sciences and inclusive services and usable technologies for healthy living and active aging.

Emilia-Romagna  is involved in a number of major initiatives in the field of personalised medicine including Hologene, Custom Implants, Italian Infrastructure for Regenerative Medicine, SUPER  HPC and Big Data and Italian Biobanks network.

ART-ER Attrattività Ricerca Territorio

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes

Policy documents

 

  1. national  SNSI - National smart specialization  https://www.invitalia.it/chi-siamo/area-media/storie/smart-specialisation-strategy-le-priorita-nazionali-per-lo-sviluppo-del-paese 

  2. national  ALISEI applied life science national cluster strategic plan  http://www.clusteralisei.it/en/strategic-plan/ 

Major initiatives

 

  1. Hologene 7  http://www.hg7porfesr.eu/en/homepage-2/

  2. Hologene 7 2.0

  3. Custom Implants  http://www.custom-implants.it/

  4. IRMI - Italian Infrastructure for Regenerative Medicine  http://www.clusteralisei.it/progetti/irmi/

  5. SUPER  HPC and Big Data 

  6. BBMRI.it  Italian Biobanks network  https://www.bbmri.it/lista-biobanche/

 

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?

  1. BBMRI  EUS3 Platform - Personalized Medicine

  2. H2020 - SMEINST - Oncosmart - ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics

  3. H2020- SMEINST- BIOFOSTE - Clinical validation of a BIOmarker panel For OSTEoarthritis diagnosis: BIOFOSTE

  4. H2020 - SC1- ADIPOA2 - Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis

SHAPIRE SOCIAL ICONS-3.jpg
SHAPIRE SOCIAL ICONS-2.jpg
SHAPIRE SOCIAL ICONS-4.jpg

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium